Skip to main content

HIV/AIDS Archives

Clinical Trials Unit lands major grant renewal

Feb. 11, 2021—Vanderbilt University Medical Center and Washington University School of Medicine in St. Louis have received renewal of a major federal grant to continue their collaboration to test and develop new treatments and vaccines against HIV/AIDS — and now COVID-19.

Read more


Key factors in HIV-1 replication

Feb. 8, 2021—HIV-1, the virus that causes AIDS, exploits inositol phosphates in T cells to aid its own assembly and maturation — suggesting that targeting inositol phosphate binding could inhibit HIV-1 replication.

Read more


HIV prevention medication not being prescribed routinely: study

Sep. 17, 2020—Only about 54% of medical practitioners surveyed say they have prescribed pre-exposure prophylaxis, or PrEP, to HIV-vulnerable patients, according to a new study by a Vanderbilt University Medical Center investigator.

Read more


Study finds zinc doesn’t reduce mortality, other health risks, for heavy alcohol users living with HIV/AIDS

Jun. 24, 2020—Zinc supplementation did not reduce mortality, cardiovascular risk, levels of inflammation or microbial translocation among people with heavy alcohol use living with HIV/AIDS, according to a Vanderbilt-led study.

Read more


VIGH awarded $3 million for building research capacity in Nigeria and Mozambique

Jun. 9, 2020—Vanderbilt Institute for Global Health (VIGH) has received a new research training grant and a renewal for an existing training program from the Fogarty International Center (FIC) of the National Institutes of Health (NIH) to build HIV-focused research capacity with key partners in Nigeria and Mozambique.

Read more


Center for AIDS Research lands NIH grant renewal

May. 7, 2020—The National Institutes of Health (NIH) has renewed its support of the Tennessee Center for AIDS Research (CFAR), a four-way partnership between Vanderbilt University Medical Center, Meharry Medical College, the Tennessee Department of Health and Nashville CARES.

Read more


Team to test app for improving HIV care for new mothers in South Africa

May. 7, 2020—As South Africans with HIV move around the country, there is a risk they will disengage from the health care system or otherwise become lost to follow-up care.

Read more


Study examines HIV drug’s potential to treat Alzheimer’s

Dec. 12, 2019—A drug used to treat and prevent HIV/AIDS is showing promise as a potential therapy for Alzheimer’s disease.

Read more


HIV/AIDS expert Nabel set for next Discovery Lecture

Nov. 6, 2019—Gary Nabel, MD, PhD, Chief Scientific Officer and Senior Vice President of Sanofi, will deliver the next Flexner Discovery Lecture on Thursday, Nov. 14.

Read more


Major grant renews AIDS education, training initiative

Jul. 24, 2019—VUMC has been awarded a five-year, nearly $23 million federal grant to continue coordinating AIDS education and training efforts in Tennessee and seven other southeastern states.

Read more


New HIV research training program launched

Sep. 20, 2018—With the help of a $1.6 million grant from the National Heart, Lung and Blood Institute, Vanderbilt University Medical Center is launching a specialized research training program called Vanderbilt Scholars in HIV and Heart, Lung, Blood and Sleep Research, or V-SCHoLARs.

Read more


A “public” target for HIV

Jun. 8, 2018—Common sequences of antibodies against HIV may be key to developing a successful vaccine strategy for the virus.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more